Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Duran Wheaton Kimble brings together range of glass, plastic product portfolios; appoints executives
March 13, 2017
By: Kristin Brooks
Managing Editor, Contract Pharma
Duran Group, following its acquisition of Wheaton Industries and merger with a Kimble Chase, has integrated these brands into a single, international brand, Duran Wheaton Kimble. The creation of this new brand brings together complementary product portfolios with a complete range of premium, purpose-built glass products, as well as plastic products and fused material-based containers. According to the company, the increased manufacturing capacity makes it possible to optimize global product availability and offer faster and easier access to the products. “We are introducing Duran Wheaton Kimble to the research, diagnostics, and specialty pharmaceuticals industries with great pride and excitement, as we feel strongly that it fills a critical need in the marketplace,” said David Koi, the new president of Wheaton Industries. “The three corporate brands under the new global branding umbrella of Duran Wheaton Kimble brings with them more than 130 years of successfully serving the life sciences market with excellence.” Including Mr. Koi, who joins the company from Thermo Fisher Scientific, where he was senior vice president, Global Portfolio Management, Fisher Scientific Channel, Duran Wheaton Kimble has named appointed two other executives. Doug Harris was named vice president of sales and marketing. He previously served as chief executive officer of NanoDetection Technology Inc., a company developing computer chip-based technology for the rapid detection of multiple biomarkers. He also worked in sales and marketing for Meridian Bioscience, Greiner Bio-One North America, and BD. Also, Stephan W. Labonté has begun serving as a member of the advisory board of Duran Group. Previously Mr. Labonté served as senior vice president of Category Management and Supplier Relationships at VWR International.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !